Search Results - "Spadafora, S."

Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project) by Bendtsen, L, Munksgaard, Sb, Tassorelli, C, Nappi, G, Katsarava, Z, Lainez, M, Leston, Ja, Fadic, R, Spadafora, S, Stoppini, A, Jensen, R

“…The objective of this article is to investigate whether headache-related disability, depression and anxiety can be reduced by detoxification and prophylactic…”
Get more information

Time’s up for prioritizing Physician Humanism into CanMEDS by Dagnone, JD, Glover-Takahashi, S, Spadafora, S, Whitehead, C

Get full text

An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy by Van Cutsem, E., Siena, S., Humblet, Y., Canon, J.-L., Maurel, J., Bajetta, E., Neyns, B., Kotasek, D., Santoro, A., Scheithauer, W., Spadafora, S., Amado, R. G., Hogan, N., Peeters, M.

“…Background: A phase 3 study demonstrated that panitumumab, a human monoclonal anti-epidermal growth factor receptor antibody, significantly prolonged…”
Get full text

The medical treatment of the actinic keratosis and the skin tumours: photodynamic therapy (PDT) by Provenzano, E, Spadafora, S

Get full text

Community-based intervention to optimise falls risk management: a randomised controlled trial by Ciaschini, P.M., Straus, S.E., Dolovich, L.R., Goeree, R.A., Leung, K.M., Woods, C.R., Zimmerman, G.M., Majumdar, S.R., Spadafora, S., Fera, L.A., Lee, H.N.

“…Background: falls are the leading causes of accidental death and fragility fractures in older adults. Interventions that assess and reduce falls risk are…”
Get full text

Community-based randomised controlled trial evaluating falls and osteoporosis risk management strategies by Ciaschini, P M, Straus, S E, Dolovich, L R, Goeree, R A, Leung, K M, Woods, C R, Zimmerman, G M, Majumdar, S R, Spadafora, S, Fera, L A, Lee, H N

“…Osteoporosis-related fractures are a significant public health concern. Interventions that increase detection and treatment of osteoporosis, as well as…”
Get full text

LBA87 A pragmatic cluster-randomized trial of ambulatory toxicity management in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer (AToM) by Krzyzanowska, M.K., Julian, J., Gu, C-S., Powis, M., Li, Q., Enright, K.A., Howell, D., Earle, C., Gandhi, S., Rask, S., Brezden-Masley, C., Dent, S.F., Hajra, L., Freedman, O., Spadafora, S., Hamm, C., Califaretti, N., Trudeau, M., Levine, M., Grunfeld, E.

Get full text

Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: Results from the Italian Psocare Registry by Piaserico, Stefano, MD, PhD, Cazzaniga, Simone, PhD Math, Chimenti, Sergio, MD, PhD, Giannetti, Alberto, MD, PhD, Maccarone, Mara, BA, Picardo, Mauro, MD, Peserico, Andrea, MD, Naldi, Luigi, MD

“…Background Some studies have shown that switching patients from one tumor necrosis factor (TNF)-alfa inhibitor to another may be beneficial when they have an…”
Get full text

An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy by Grünwald, Viktor, Karakiewicz, Pierre I, Bavbek, Sevil E, Miller, Kurt, Machiels, Jean-Pascal, Lee, Se-Hoon, Larkin, James, Bono, Petri, Rha, Sun Young, Castellano, Daniel, Blank, Christian U, Knox, Jennifer J, Hawkins, Robert, Anak, Oezlem, Rosamilia, Marianne, Booth, Jocelyn, Pirotta, Nicoletta, Bodrogi, István

“…Abstract Background and objectives The RECORD-1 trial established the clinical benefit of everolimus in patients with metastatic renal cell carcinoma (mRCC)…”
Get full text

Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry by Gisondi, P., Cazzaniga, S., Chimenti, S., Giannetti, A., Maccarone, M., Picardo, M., Girolomoni, G., Naldi, L.

“…Objective  To evaluate variations in laboratory parameters and diagnoses of selected clinical conditions up to 16 weeks after starting a new systemic psoriasis…”
Get full text

Optimal systemic therapy for early breast cancer in women: a clinical practice guideline by Eisen, A, Fletcher, G G, Gandhi, S, Mates, M, Freedman, O C, Dent, S F, Trudeau, M E

“…The Breast Cancer Disease Site Group of Cancer Care Ontario identified the need for new guidelines for the adjuvant systemic therapy of early-stage breast…”
Get full text

Reasons for Delay in Time to Initiation of Adjuvant Chemotherapy for Colon Cancer: a Multi-Institution Study by Biagi, J., Burkes, R., Brezden-Masley, C., Zbuk, K., Meyers, B., Levine, O., Spadafora, S., Welch, S., Davdani, S., Hopman, W., Booth, C.M., Goodwin, R.

Get full text

577PREASONS FOR DELAY IN TIME TO INITIATION OF ADJUVANT CHEMOTHERAPY FOR COLON CANCER: A MULTI-INSTITUTION STUDY by Biagi, J., Burkes, R., Brezden-Masley, C., Zbuk, K., Meyers, B., Levine, O., Spadafora, S., Welch, S., Davdani, S., Hopman, W., Booth, C.M., Goodwin, R.

“…Abstract Aim: Although adjuvant chemotherapy (AC) has been shown to improve survival in patients with colon cancer (CC), meta-analyses have suggested decreased…”
Get full text

EHMTI-0327. Information and communication technology for improving the management of medication overuse headache: results of the comoestas multicentric, multinational study: Doc 925 by Tassorelli, C, Jensen, Rh, De Icco, R, Allena, M, Katzarava, Z, Lainez, Jm, Leston, Ja, Fadic, R, Spadafora, S, Pagani, M, Giuseppe, N

Get full text

EHMTI-0327. Information and communication technology for improving the management of medication overuse headache: results of the comoestas multicentric, multinational study by Tassorelli, C, Jensen, RH, De Icco, R, Allena, M, Katzarava, Z, Lainez, JM, Leston, JA, Fadic, R, Spadafora, S, Pagani, M, Giuseppe, N

Get full text

A 24-month subgroup analysis of the effect of denosumab on bone mineral density in women with breast cancer undergoing aromatase inhibitor therapy by Ellis, GK, Bone, HG, Chlebowski, R, Paul, D, Spadafora, S, Fan, M, Kim, D

“…Abstract Abstract #2106 Background: Accelerated bone loss and fracture risk are expected consequences of adjuvant aromatase inhibitor (AI) therapy. We…”
Get full text

Subgroup analysis of a randomized, phase III study of the effect of denosumab in women with nonmetastatic breast cancer receiving aromatase inhibitor (AI) therapy by Ellis, G. K., Bone, H. G., Chlebowski, R. T., Paul, D., Spadafora, S., Smith, J., Fan, M., Jun, S.

“…Abstract only…”
Get full text

Epidural hematoma following epidural analgesia in a patient receiving unfractionated heparin for thromboprophylaxis by Sandhu, Harminder, Morley-Forster, Patricia, Spadafora, Salvatore

“…The practice of providing postoperative epidural analgesia for patients receiving deep venous thromboprophylaxis with unfractionated heparin is common. This…”
Get full text

Single agent Gemcitabine for elderly patients with non small cell lung cancer (NSCLC): A phase II study by Burkes, R.L, Wilson, J, Shepherd, F.A, Spadafora, S, Iglesias, J

Get full text

168 A pilot study of high dose chemotherapy and irradiation with NEUPOGEN (G-CSF) in limited disease small cell lung cancer (SCLC) by Goss, G., Lochrin, C., Gertler, S., Stewart, Doug, Cross, P., Agboola, O., Stewart, David, Spadafora, S., Hewitt, A., Bociek, G., Evans, W., Yau, J.

Get full text